Your browser doesn't support javascript.
loading
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
Gatti, Milo; Raschi, Emanuel; De Ponti, Fabrizio.
  • Gatti M; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. milo.gatti2@unibo.it.
  • Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.
  • De Ponti F; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.
Eur J Clin Microbiol Infect Dis ; 40(6): 1169-1176, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33415492

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Agranulocitosis / Inhibidores de beta-Lactamasas / Lactamas / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Agranulocitosis / Inhibidores de beta-Lactamasas / Lactamas / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article